# Takeda Pharmaceutical Company Limited (NYSE: TAK), Yamaguchi, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf

> Inspection records and compliance data for Takeda Pharmaceutical Company Limited in Yamaguchi, 743-0011. 10 FDA inspections on record (1 OAI), 2 Form 483s, last inspected November 06, 2023. Publicly traded as NYSE: TAK.

---

## Details

- Name: Takeda Pharmaceutical Company Limited
- FEI Number: 3004664162
- Address Line 1: Hikari
- City: Yamaguchi
- State: 743-0011
- Zip Code: Japan
- Country Name: Japan
- Address: Hikari, Yamaguchi, 743-0011 Japan, Japan
- Country: Japan

## Stock

- Stock ticker: TAK
- Exchange: NYSE
- Share price: $21.13
- Market cap: $66.8B
- Price as of: November 13, 2026

## Related Documents

- [483 - Takeda Pharmaceutical Company Limited - 2023-11-06](https://www.keypedia.com/records/483/takeda-pharmaceutical-company-limited/9830bf69-579a-4bc0-bf7c-8ad2b78a6e53) — source: FDA, date: November 6, 2023
- [FDA Inspection 1224917 - Takeda Pharmaceutical Company Limited - 2023-11-06](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/01fa4df9-a921-4e9e-be5f-bd7dcb845d86) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 6, 2023
- [483 - Takeda Pharmaceutical Company Limited - 2023-11-01](https://www.keypedia.com/records/483/takeda-pharmaceutical-company-limited/1896dda4-c7e8-4da9-b91a-daba1da128bc) — source: FDA, date: November 1, 2023
- [483 - Takeda Pharmaceutical Company Limited - 2023-05-24](https://www.keypedia.com/records/483/takeda-pharmaceutical-company-limited/ac78eb79-a4fa-40e6-a809-4bde4790ca58) — source: FDA, date: May 24, 2023
- [FDA Inspection 1218059 - Takeda Pharmaceutical Company Limited - 2023-05-24](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/cdd33b98-5693-473b-a7f6-dbe8d234604d) — source: FDA, date: May 24, 2023
- [483 - Takeda Pharmaceutical Company Limited - 2021-07-19](https://www.keypedia.com/records/483/takeda-pharmaceutical-company-limited/d7328c43-e92f-449d-bccf-293394b50bdc) — source: FDA, date: July 19, 2021
- FDA Inspection 1148832 - Takeda Pharmaceutical Company Limited - 2021-07-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2021
- [EIR - Takeda Pharmaceutical Company Limited - 2019-11-26](https://www.keypedia.com/records/eir/takeda-pharmaceutical-company-limited/921c7f71-9c2e-46ae-90ad-9ea313e0e463) — source: FDA, date: November 26, 2019
- [483 - Takeda Pharmaceutical Company Limited - 2019-11-26](https://www.keypedia.com/records/483/takeda-pharmaceutical-company-limited/58fc4bcb-d16e-4868-88eb-9a01737e1cc2) — source: FDA, date: November 26, 2019
- [FDA Inspection 1111495 - Takeda Pharmaceutical Company Limited - 2019-11-26](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/81193b1d-47fb-46c4-861a-52550748864c) — classification: Official Action Indicated (OAI), source: FDA, date: November 26, 2019
- FDA Inspection 1033814 - Takeda Pharmaceutical Company Limited - 2017-11-07 — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2017
- FDA Inspection 951603 - Takeda Pharmaceutical Company Limited - 2015-10-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2015
- FDA Inspection 851370 - Takeda Pharmaceutical Company Limited - 2013-09-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2013
- FDA Inspection 793421 - Takeda Pharmaceutical Company Limited - 2012-07-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 20, 2012
- FDA Inspection 748712 - Takeda Pharmaceutical Company Limited - 2011-09-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2011
- FDA Inspection 682751 - Takeda Pharmaceutical Company Limited - 2010-09-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2010

## Related Companies

- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/801e26ba-26ed-40ab-84c9-d4ee2e24e42e)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3)
- [Adare Pharmaceuticals, Inc.](https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5)
- [EUGIA Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/c9c73721-7ca2-4457-89c9-f1001123e141)
- [POINT Biopharma USA Inc.](https://www.keypedia.com/companies/point-biopharma-usa-inc/f4a8cb71-7a5c-4407-a6c8-6765aacfb8da)
- [Apothecon Pharmaceuticals Private Limited](https://www.keypedia.com/companies/apothecon-pharmaceuticals-private-limited/9fd69fd5-d0ef-458e-bdf3-b9b73b75f954)
- [Qilu Antibiotics Pharmaceutical Co. , Ltd.](https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c)
- [NerPharMa S.r.l.](https://www.keypedia.com/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391)
- [Biocon Biologics Limited](https://www.keypedia.com/companies/biocon-biologics-limited/d4e5402d-7d48-48ee-911b-8a78bfb97a67)
- [Fujian Genohope Biotech Ltd.](https://www.keypedia.com/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9)

## Related Officers

- [Steven M. Weinman](https://www.keypedia.com/people/steven-m-weinman/66ffc074-e34a-4b53-a525-0d4a25c6a220)
- [Ileana Barreto-Petit](https://www.keypedia.com/people/ileana-barreto-petit/e5c865ac-14a2-47d4-954b-464a865e8684)
- [company_representative](https://www.keypedia.com/people/kotaro-watanabe/0f72bad2-46f2-4fbf-8348-00d926f34026)
- [company_representative](https://www.keypedia.com/people/gerard-greco/1be79833-3a3e-41f8-b36c-1a4c53177ad9)
- [Vincent Thomas](https://www.keypedia.com/people/vincent-thomas/0925480c-5d8c-411f-86ee-5e4b924f8c12)
- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)